Monte Rosa Therapeutics Inc (GLUE) — Free Cash Flow Generation Index
Monte Rosa Therapeutics Inc (GLUE) has a Free Cash Flow Generation Index of 0.99x as of September 2025. Free cash flow of $99.78 Million represents 1% of operating cash flow ($100.43 Million). Explore GLUE capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Monte Rosa Therapeutics Inc Free Cash Flow Generation Index (2024–2024)
Historical FCF Generation Index trend for Monte Rosa Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see GLUE cash flow conversion.
Annual Free Cash Flow Generation for Monte Rosa Therapeutics Inc (2024–2024)
Year-by-year Free Cash Flow Generation Index for Monte Rosa Therapeutics Inc. Check Monte Rosa Therapeutics Inc (GLUE) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | $38.01 Million | $42.00 Million | $3.99 Million | — |